Population Health and Genetic Testing

  • Matthew J. Ferber, PhD, FACMG

    Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo


With the completion of the human genome nearly two decades ago, consumers, patients, and physicians are wondering when genetic testing will go PRIME TIME.  While the diagnostic utility of genetic testing continues to steadily increase, the idea of population health driven genetic testing is just getting started.  This talk will explore how genetic testing can be used to better manage the healthcare of large populations, the challenges and concerns with launching such a program, and how it is different than diagnostic genetic testing.

Learning Objectives:

1. Define how genetic testing fits into population health management strategies

2. Understand how genetic testing for screening purposes is different than that used for diagnostic purposes

3. Describe the value of population health genetic screening to society